# Wolverine World Wide Inc: financial statements, quarterly WWW · NYSE · CIK 110471 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 30 Pages: [Overview](/companies/www.md) · [Financials](/companies/www/financials.md) · [Filings](/companies/www/filings.md) · [Insiders](/companies/www/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/www/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [528](/filings/0000110471-24-000176.md) | [527 d](/filings/0001628280-26-012614.md) | [395](/filings/0000110471-25-000085.md) | [425](/filings/0000110471-25-000125.md) | [440](/filings/0001628280-25-049956.md) | [495 d](/filings/0001628280-26-012614.md) | [412](/filings/0001628280-26-034967.md) | [474](/filings/0001628280-26-056524.md) | [470](/filings/0001628280-25-049956.md) | [518 d](/filings/0001628280-26-012614.md) | [458](/filings/0001628280-26-034967.md) | [506](/filings/0001628280-26-056524.md) | | Cost of revenue | $m | [312](/filings/0000110471-24-000176.md) | [332 d](/filings/0001628280-26-012614.md) | [214](/filings/0001628280-25-049956.md) | [243](/filings/0001628280-25-049956.md) | [242](/filings/0001628280-25-049956.md) | [279 d](/filings/0001628280-26-012614.md) | [216](/filings/0001628280-26-034967.md) | [250](/filings/0001628280-26-056524.md) | [247](/filings/0001628280-25-049956.md) | [274 d](/filings/0001628280-26-012614.md) | [240](/filings/0001628280-26-034967.md) | [271](/filings/0001628280-26-056524.md) | | Gross profit | $m | [215](/filings/0000110471-24-000176.md) | [194 d](/filings/0001628280-26-012614.md) | [181](/filings/0000110471-25-000085.md) | [183](/filings/0000110471-25-000125.md) | [199](/filings/0001628280-25-049956.md) | [216 d](/filings/0001628280-26-012614.md) | [196](/filings/0001628280-26-034967.md) | [224](/filings/0001628280-26-056524.md) | [223](/filings/0001628280-25-049956.md) | [243 d](/filings/0001628280-26-012614.md) | [218](/filings/0001628280-26-034967.md) | [235](/filings/0001628280-26-056524.md) | | Selling, general and administrative | $m | [203](/filings/0000110471-24-000176.md) | [245 d](/filings/0001628280-26-012614.md) | [177](/filings/0000110471-25-000085.md) | [167](/filings/0000110471-25-000125.md) | [171](/filings/0001628280-25-049956.md) | [175 d](/filings/0001628280-26-012614.md) | [172](/filings/0001628280-26-034967.md) | [182](/filings/0001628280-26-056524.md) | [183](/filings/0001628280-25-049956.md) | [192 d](/filings/0001628280-26-012614.md) | [183](/filings/0001628280-26-034967.md) | [187](/filings/0001628280-26-056524.md) | | Operating income | $m | [27.3](/filings/0000110471-24-000176.md) | [(186) d](/filings/0001628280-26-012614.md) | [(3.1)](/filings/0000110471-25-000085.md) | [29.1](/filings/0000110471-25-000125.md) | [34.7](/filings/0001628280-25-049956.md) | [37.8 d](/filings/0001628280-26-012614.md) | [21.0](/filings/0001628280-26-034967.md) | [40.7](/filings/0001628280-26-056524.md) | [39.6](/filings/0001628280-25-049956.md) | [48.9 d](/filings/0001628280-26-012614.md) | [33.9](/filings/0001628280-26-034967.md) | [47.3](/filings/0001628280-26-056524.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [0.4](/filings/0000110471-24-000176.md) | [(111) d](/filings/0001628280-26-012614.md) | [(0.7)](/filings/0001628280-25-049956.md) | [2.3](/filings/0001628280-25-049956.md) | [5.0](/filings/0001628280-25-049956.md) | [2.7 d](/filings/0001628280-26-012614.md) | [1.3](/filings/0001628280-26-034967.md) | [4.6](/filings/0001628280-26-056524.md) | [6.8](/filings/0001628280-25-049956.md) | [7.8 d](/filings/0001628280-26-012614.md) | [5.2](/filings/0001628280-26-034967.md) | [7.9](/filings/0001628280-26-056524.md) | | Net income | $m | [8.6](/filings/0000110471-24-000176.md) | [(90.1) d](/filings/0001628280-26-012614.md) | [(14.9)](/filings/0001628280-25-049956.md) | [13.8](/filings/0001628280-25-049956.md) | [23.2](/filings/0001628280-25-049956.md) | [23.1 d](/filings/0001628280-26-012614.md) | [12.1](/filings/0001628280-26-034967.md) | [26.8](/filings/0001628280-26-056524.md) | [25.1](/filings/0001628280-25-049956.md) | [31.8 d](/filings/0001628280-26-012614.md) | [20.2](/filings/0001628280-26-034967.md) | [31.2](/filings/0001628280-26-056524.md) | | Diluted EPS | $ per share | [0.11](/filings/0000110471-24-000176.md) | not reported | [(0.19)](/filings/0001628280-25-049956.md) | [0.17](/filings/0001628280-25-049956.md) | [0.28](/filings/0001628280-25-049956.md) | not reported | [0.15](/filings/0001628280-26-034967.md) | [0.32](/filings/0001628280-26-056524.md) | [0.30](/filings/0001628280-25-049956.md) | not reported | [0.24](/filings/0001628280-26-034967.md) | [0.37](/filings/0001628280-26-056524.md) | | Basic EPS | $ per share | [0.11](/filings/0000110471-24-000176.md) | not reported | [(0.19)](/filings/0001628280-25-049956.md) | [0.17](/filings/0001628280-25-049956.md) | [0.28](/filings/0001628280-25-049956.md) | not reported | [0.15](/filings/0001628280-26-034967.md) | [0.32](/filings/0001628280-26-056524.md) | [0.30](/filings/0001628280-25-049956.md) | not reported | [0.24](/filings/0001628280-26-034967.md) | [0.37](/filings/0001628280-26-056524.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current assets | $m | [1,097](/filings/0000110471-24-000176.md) | [1,025](/filings/0000110471-25-000046.md) | [826](/filings/0000110471-25-000085.md) | [791](/filings/0000110471-25-000125.md) | [772](/filings/0001628280-25-049956.md) | [696](/filings/0001628280-26-012614.md) | [701](/filings/0001628280-26-034967.md) | [810](/filings/0001628280-26-056524.md) | [717](/filings/0001628280-25-049956.md) | [729](/filings/0001628280-26-056524.md) | [672](/filings/0001628280-26-034967.md) | [736](/filings/0001628280-26-056524.md) | | Total assets | $m | [2,231](/filings/0000110471-24-000176.md) | [2,063](/filings/0000110471-25-000046.md) | [1,853](/filings/0000110471-25-000085.md) | [1,796](/filings/0000110471-25-000125.md) | [1,766](/filings/0001628280-25-049956.md) | [1,674](/filings/0001628280-26-012614.md) | [1,691](/filings/0001628280-26-034967.md) | [1,815](/filings/0001628280-26-056524.md) | [1,707](/filings/0001628280-25-049956.md) | [1,709](/filings/0001628280-26-056524.md) | [1,640](/filings/0001628280-26-034967.md) | [1,707](/filings/0001628280-26-056524.md) | | Current liabilities | $m | [852](/filings/0000110471-24-000176.md) | [869](/filings/0000110471-25-000046.md) | [730](/filings/0000110471-25-000085.md) | [666](/filings/0000110471-25-000125.md) | [619](/filings/0001628280-25-049956.md) | [533](/filings/0001628280-26-012614.md) | [551](/filings/0001628280-26-034967.md) | [647](/filings/0001628280-26-056524.md) | [534](/filings/0001628280-25-049956.md) | [521](/filings/0001628280-26-056524.md) | [438](/filings/0001628280-26-034967.md) | [475](/filings/0001628280-26-056524.md) | | Long-term debt | $m | [716](/filings/0000110471-24-000176.md) | [606](/filings/0000110471-25-000046.md) | [582](/filings/0000110471-25-000085.md) | [580](/filings/0000110471-25-000125.md) | [568](/filings/0001628280-25-049956.md) | [568](/filings/0001628280-26-012614.md) | [566](/filings/0001628280-26-034967.md) | [564](/filings/0001628280-26-056524.md) | [546](/filings/0001628280-25-049956.md) | [547](/filings/0001628280-26-056524.md) | [547](/filings/0001628280-26-034967.md) | [547](/filings/0001628280-26-056524.md) | | Current portion of debt | $m | [10.0](/filings/0000110471-24-000176.md) | [10.0](/filings/0000110471-25-000046.md) | [10.0](/filings/0000110471-25-000085.md) | [10.0](/filings/0000110471-25-000125.md) | [10.0](/filings/0001628280-25-049956.md) | [10.0](/filings/0001628280-26-012614.md) | [10.0](/filings/0001628280-26-034967.md) | [10.0](/filings/0001628280-26-056524.md) | [0.0](/filings/0001628280-25-049956.md) | [0.0](/filings/0001628280-26-056524.md) | [0.0](/filings/0001628280-26-034967.md) | [0.0](/filings/0001628280-26-056524.md) | | Shareholders' equity | $m | [342](/filings/0000110471-24-000176.md) | [279](/filings/0000110471-25-000046.md) | [253](/filings/0000110471-25-000085.md) | [262](/filings/0000110471-25-000125.md) | [295](/filings/0001628280-25-049956.md) | [313](/filings/0001628280-26-012614.md) | [317](/filings/0001628280-26-034967.md) | [351](/filings/0001628280-26-056524.md) | [377](/filings/0001628280-25-049956.md) | [408](/filings/0001628280-26-056524.md) | [416](/filings/0001628280-26-034967.md) | [449](/filings/0001628280-26-056524.md) | - Cash and equivalents: not reported - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(38.9) d](/filings/0000110471-24-000176.md) | [115 d](/filings/0001628280-26-012614.md) | [(37.2)](/filings/0000110471-25-000085.md) | [26.7 d](/filings/0000110471-25-000125.md) | [108 d](/filings/0001628280-25-049956.md) | [82.4 d](/filings/0001628280-26-012614.md) | [(83.8)](/filings/0001628280-26-034967.md) | [44.6 d](/filings/0001628280-26-056524.md) | [33.0 d](/filings/0001628280-25-049956.md) | [146 d](/filings/0001628280-26-012614.md) | [(83.2)](/filings/0001628280-26-034967.md) | [86.6 d](/filings/0001628280-26-056524.md) | | Capital expenditure | $m | [4.3 d](/filings/0000110471-24-000176.md) | [(3.9) d](/filings/0001628280-26-012614.md) | [5.1](/filings/0000110471-25-000085.md) | [3.0 d](/filings/0000110471-25-000125.md) | [4.1 d](/filings/0001628280-25-049956.md) | [8.0 d](/filings/0001628280-26-012614.md) | [7.6](/filings/0001628280-26-034967.md) | [3.4 d](/filings/0001628280-26-056524.md) | [2.9 d](/filings/0001628280-25-049956.md) | [0.6 d](/filings/0001628280-26-012614.md) | [1.7](/filings/0001628280-26-034967.md) | [2.4 d](/filings/0001628280-26-056524.md) | | Dividends paid | $m | [8.1 d](/filings/0000110471-24-000176.md) | [8.1 d](/filings/0001628280-26-012614.md) | [8.1](/filings/0000110471-25-000085.md) | [8.1 d](/filings/0000110471-25-000125.md) | [8.2 d](/filings/0001628280-25-049956.md) | [8.1 d](/filings/0001628280-26-012614.md) | [8.5](/filings/0001628280-26-034967.md) | [8.2 d](/filings/0001628280-26-056524.md) | [8.3 d](/filings/0001628280-25-049956.md) | [8.3 d](/filings/0001628280-26-012614.md) | [8.7](/filings/0001628280-26-034967.md) | [8.3 d](/filings/0001628280-26-056524.md) | | Share repurchases | $m | [0.0 d](/filings/0000110471-23-000147.md) | [0.0 d](/filings/0001628280-26-012614.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2022 (2022-04-02) | Q2 FY2022 (2022-07-02) | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [81.9](/filings/0000110471-23-000066.md) | [79.9](/filings/0000110471-23-000115.md) | [78.9](/filings/0000110471-23-000147.md) | [79.2](/filings/0000110471-24-000110.md) | [79.5](/filings/0000110471-24-000151.md) | [79.5](/filings/0000110471-24-000176.md) | [79.8](/filings/0000110471-25-000085.md) | [80.0](/filings/0000110471-24-000151.md) | [80.0](/filings/0001628280-25-049956.md) | [80.8](/filings/0001628280-26-034967.md) | [81.7](/filings/0001628280-25-049956.md) | [81.7](/filings/0001628280-26-034967.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 82,066,339 at 2026-07-27, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056524.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.